Cite
MLA Citation
Zhijie Ding et al.. “S723 Improvements in Work Productivity Loss and Associated Cost Reductions with Ustekinumab and Adalimumab in Biologic-Naïve Patients with Moderately-to-Severely Active Crohn's Disease: Results From the SEAVUE Study.” American journal of gastroenterology, vol. 116, n.d., p. S330. http://access.bl.uk/ark:/81055/vdc_100144524038.0x000037